Jaguar Health (JAGX) Net Margin (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Net Margin data on file, last reported at 34.6% in Q1 2026.

• On a quarterly basis, Net Margin rose 43802.0% year-over-year to 34.6% in Q1 2026; TTM through Mar 2026 was 170.5%, a 17758.0% increase from a year earlier, with the FY2025 full-year figure at 465.42%, down 13612.0% from the prior year.
• Net Margin for Q1 2026 stood at 34.6%, up from 716.94% in the prior quarter.
• Over the last five years, Net Margin for JAGX reached as high as 34.6% in Q1 2026 and fell as low as 89930.0% in Q1 2022.
• Historically, Net Margin has averaged 8578.89% across 5 years, with a median of 392.43% in 2024.
• Across the five-year window, Net Margin tumbled 8893588 bps in 2022 and jumped 6281444 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 23690.62% in 2022, then surged by 98 bps to 398.7% in 2023, then increased by 27 bps to 291.65% in 2024, then slumped by 146 bps to 716.94% in 2025, then soared by 95 bps to 34.6% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 34.6% in Q1 2026, 716.94% in Q4 2025, and 312.94% in Q3 2025.